Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention

IF 2.2 MedComm – Oncology Pub Date : 2025-02-17 DOI:10.1002/mog2.70012
Lin Tang, Shao-Cong Peng, Xiao-Wan Zhuang, Yan He, Yu-Xiang Song, Hao Nie, Can-Can Zheng, Zhen-Yu Pan, Alfred King-Yin Lam, Ming-Liang He, Xing-Yuan Shi, Bin Li, Wen Wen Xu
{"title":"Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention","authors":"Lin Tang,&nbsp;Shao-Cong Peng,&nbsp;Xiao-Wan Zhuang,&nbsp;Yan He,&nbsp;Yu-Xiang Song,&nbsp;Hao Nie,&nbsp;Can-Can Zheng,&nbsp;Zhen-Yu Pan,&nbsp;Alfred King-Yin Lam,&nbsp;Ming-Liang He,&nbsp;Xing-Yuan Shi,&nbsp;Bin Li,&nbsp;Wen Wen Xu","doi":"10.1002/mog2.70012","DOIUrl":null,"url":null,"abstract":"<p>Metastasis remains a leading cause of cancer-related deaths, defined by a complex, multi-step process in which tumor cells spread and form secondary growths in distant tissues. Despite substantial progress in understanding metastasis, the molecular mechanisms driving this process and the development of effective therapies remain incompletely understood. Elucidating the molecular pathways governing metastasis is essential for the discovery of innovative therapeutic targets. The rapid advancements in sequencing technologies and the expansion of biological databases have significantly deepened our understanding of the molecular drivers of metastasis and associated drug resistance. This review focuses on the molecular drivers of metastasis, particularly the roles of genetic mutations, epigenetic changes, and post-translational modifications in metastasis progression. We also examine how the tumor microenvironment influences metastatic behavior and explore emerging therapeutic strategies, including targeted therapies and immunotherapies. Finally, we discuss future research directions, stressing the importance of novel treatment approaches and personalized strategies to overcome metastasis and improve patient outcomes. By integrating contemporary insights into the molecular basis of metastasis and therapeutic innovation, this review provides a comprehensive framework to guide future research and clinical advancements in metastatic cancer.</p>","PeriodicalId":100902,"journal":{"name":"MedComm – Oncology","volume":"4 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mog2.70012","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedComm – Oncology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mog2.70012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Metastasis remains a leading cause of cancer-related deaths, defined by a complex, multi-step process in which tumor cells spread and form secondary growths in distant tissues. Despite substantial progress in understanding metastasis, the molecular mechanisms driving this process and the development of effective therapies remain incompletely understood. Elucidating the molecular pathways governing metastasis is essential for the discovery of innovative therapeutic targets. The rapid advancements in sequencing technologies and the expansion of biological databases have significantly deepened our understanding of the molecular drivers of metastasis and associated drug resistance. This review focuses on the molecular drivers of metastasis, particularly the roles of genetic mutations, epigenetic changes, and post-translational modifications in metastasis progression. We also examine how the tumor microenvironment influences metastatic behavior and explore emerging therapeutic strategies, including targeted therapies and immunotherapies. Finally, we discuss future research directions, stressing the importance of novel treatment approaches and personalized strategies to overcome metastasis and improve patient outcomes. By integrating contemporary insights into the molecular basis of metastasis and therapeutic innovation, this review provides a comprehensive framework to guide future research and clinical advancements in metastatic cancer.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肿瘤转移:机制洞察和治疗干预
转移仍然是癌症相关死亡的主要原因,它是一个复杂的多步骤过程,肿瘤细胞在远处组织中扩散并形成继发性生长。尽管在了解转移方面取得了实质性进展,但驱动这一过程的分子机制和有效治疗方法的发展仍然不完全清楚。阐明控制转移的分子途径对于发现创新的治疗靶点至关重要。测序技术的快速发展和生物数据库的扩展,极大地加深了我们对转移和相关耐药的分子驱动因素的理解。本文综述了转移的分子驱动因素,特别是基因突变、表观遗传改变和翻译后修饰在转移过程中的作用。我们还研究了肿瘤微环境如何影响转移行为,并探索了新兴的治疗策略,包括靶向治疗和免疫治疗。最后,我们讨论了未来的研究方向,强调了新的治疗方法和个性化策略对克服转移和改善患者预后的重要性。通过整合当代对转移的分子基础和治疗创新的见解,本综述为指导转移性癌症的未来研究和临床进展提供了一个全面的框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The Acetyl-CoA-NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance SIRT7 Orchestrates Ligand-Dependent ERα Signaling Rewiring to Drive Tamoxifen Resistance in ERα-positive Breast Cancer Cancer Comorbidities: Clinical Impacts, Mechanistic Insights, and Management Strategies Metabolic Reprogramming of the Pre-Metastatic Niche: A Sweet Spot for Anti-Tumor Immunity RNA-Binding Proteins and Ferroptosis in Cancer: Mechanism and Therapeutic Implications
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1